The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ALECTOR INC | COM | 014442107 | 1,935,000 | 900,000 | SH | SOLE | 900,000 | 0 | 0 | |||
| ALUMIS INC | COM | 022307102 | 2,863,900 | 130,000 | SH | SOLE | 130,000 | 0 | 0 | |||
| AMYLYX PHARMACEUTICALS INC | COM | 03237H101 | 1,556,800 | 112,000 | SH | SOLE | 112,000 | 0 | 0 | |||
| APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 2,011,500 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | |||
| BEAM THERAPEUTICS INC | COM | 07373V105 | 11,351,135 | 476,338 | SH | SOLE | 476,338 | 0 | 0 | |||
| BIOCRYST PHARMACEUTICALS INC | COM | 09058V103 | 9,520,000 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | |||
| BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | 2,655,030 | 47,000 | SH | SOLE | 47,000 | 0 | 0 | |||
| CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | 27,437,800 | 865,000 | SH | SOLE | 865,000 | 0 | 0 | |||
| CG ONCOLOGY INC | COM | 156944100 | 19,749,024 | 291,800 | SH | SOLE | 291,800 | 0 | 0 | |||
| COGENT BIOSCIENCES INC | COM | 19240Q201 | 45,061,783 | 1,170,740 | SH | SOLE | 1,170,740 | 0 | 0 | |||
| CULLINAN THERAPEUTICS INC | COM | 230031106 | 7,531,300 | 530,000 | SH | SOLE | 530,000 | 0 | 0 | |||
| CYTOMX THERAPEUTICS INC. | COM | 23284F105 | 21,385,000 | 4,550,000 | SH | SOLE | 4,550,000 | 0 | 0 | |||
| DBV TECHNOLOGIES S A | SPONSORED ADS | 23306J309 | 5,535,850 | 265,000 | SH | SOLE | 265,000 | 0 | 0 | |||
| DESIGN THERAPEUTICS INC | COM | 25056L103 | 2,212,056 | 207,900 | SH | SOLE | 207,900 | 0 | 0 | |||
| EDGEWISE THERAPEUTICS INC | COM | 28036F105 | 315,000 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | |||
| ENGENE HOLDINGS INC | COM | 29286M105 | 1,430,100 | 210,000 | SH | SOLE | 210,000 | 0 | 0 | |||
| IMMUNOCORE HLDGS PLC | ADS | 45258D105 | 1,756,177 | 58,248 | SH | SOLE | 58,248 | 0 | 0 | |||
| KALVISTA PHARMACEUTICALS INC | COM | 483497103 | 20,558,769 | 1,021,300 | SH | SOLE | 1,021,300 | 0 | 0 | |||
| KRYSTAL BIOTECH INC | COM | 501147102 | 5,683,040 | 22,000 | SH | SOLE | 22,000 | 0 | 0 | |||
| MBX BIOSCIENCES INC | COM | 55287L101 | 6,298,350 | 211,000 | SH | SOLE | 211,000 | 0 | 0 | |||
| NURIX THERAPEUTICS INC | COM | 67080M103 | 7,130,000 | 460,000 | SH | SOLE | 460,000 | 0 | 0 | |||
| PHARVARIS N V | COM | N69605108 | 13,439,938 | 475,750 | SH | SOLE | 475,750 | 0 | 0 | |||
| PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | 4,005,200 | 38,000 | SH | SOLE | 38,000 | 0 | 0 | |||
| RELAY THERAPEUTICS INC | COM | 75943R102 | 5,342,613 | 536,946 | SH | SOLE | 536,946 | 0 | 0 | |||
| SUPERNUS PHARMACEUTICALS | COM | 868459108 | 1,033,800 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | |||
| SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 43,332,800 | 1,855,000 | SH | SOLE | 1,855,000 | 0 | 0 | |||
| TRAVERE THERAPEUTICS INC | COM | 89422G107 | 5,276,496 | 177,600 | SH | SOLE | 177,600 | 0 | 0 | |||
| TYRA BIOSCIENCES INC | COM | 90240B106 | 13,405,000 | 350,000 | SH | SOLE | 350,000 | 0 | 0 | |||
| UNITED THERAPEUTICS CORP DEL | COM | 91307C102 | 8,894,700 | 15,000 | SH | SOLE | 15,000 | 0 | 0 | |||
| UROGEN PHARMA LTD | COM | M96088105 | 3,955,600 | 220,000 | SH | SOLE | 220,000 | 0 | 0 | |||
| VAXCYTE INC | COM | 92243G108 | 18,391,815 | 316,500 | SH | SOLE | 316,500 | 0 | 0 | |||
| VERA THERAPEUTICS INC | CL A | 92337R101 | 19,410,975 | 482,500 | SH | SOLE | 482,500 | 0 | 0 | |||
| VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 10,463,250 | 534,931 | SH | SOLE | 534,931 | 0 | 0 | |||
| WAVE LIFE SCIENCES LTD | SHS | Y95308105 | 1,289,384 | 177,846 | SH | SOLE | 177,846 | 0 | 0 | |||